T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Corning
GLW
$137B
| $810M | 0.11% |
24,377,725
-8,519,363
| -26% | -$273M |
|
202
Verisk Analytics
VRSK
$23.6B
| $807M | 0.11% |
5,510,243
-1,000,996
| -15% | -$141M |
|
203
Bunge Global
BG
$21.4B
| $806M | 0.11% |
14,472,099
+1,423,416
| +11% | +$75.9M |
|
204
Fidelity National Financial
FNF
$12.8B
| $799M | 0.11% |
20,632,028
-32,979
| -0.2% | -$1.24M |
|
205
Accenture
ACN
$110B
| $795M | 0.11% |
4,300,693
-15,607
| -0.4% | -$2.8M |
|
|
206
NVIDIA
NVDA
$5.27T
| $774M | 0.11% |
188,451,360
-384,127,720
| -67% | -$1.59B |
|
|
NEE.PRR
207
DELISTED
NextEra Energy, Inc.
NEE.PRR
| $771M | 0.11% |
11,774,767
+180,166
| +2% | +$11.4M |
|
208
Xcel Energy
XEL
$48.5B
| $771M | 0.11% |
12,954,595
-186,089
| -1% | -$10.7M |
|
209
Fox Class B
FOX
$23.2B
| $748M | 0.11% |
20,482,811
+8,775,607
| +75% | +$318M |
|
|
DNKN
210
DELISTED
Dunkin' Brands Group, Inc.
DNKN
| $740M | 0.1% |
9,287,697
-1,118,749
| -11% | -$85.1M |
|
211
BP
BP
$111B
| $739M | 0.1% |
18,009,651
-1,161,219
| -6% | -$48.7M |
|
212
EOG Resources
EOG
$75.2B
| $728M | 0.1% |
7,809,467
-278,540
| -3% | -$25.9M |
|
213
MarketAxess Holdings
MKTX
$5.72B
| $716M | 0.1% |
2,228,517
+42,066
| +2% | +$12.2M |
|
214
Dow Inc
DOW
$22.6B
| $714M | 0.1% |
+14,487,361
| New | +$765M |
|
215
Zimmer Biomet
ZBH
$18.5B
| $713M | 0.1% |
6,235,830
+182,316
| +3% | +$21.4M |
|
216
CF Industries
CF
$17.8B
| $709M | 0.1% |
15,177,727
+3,170,180
| +26% | +$138M |
|
217
Molina Healthcare
MOH
$10.2B
| $709M | 0.1% |
4,950,577
-1,103,531
| -18% | -$151M |
|
218
Twilio
TWLO
$39.3B
| $708M | 0.1% |
5,191,487
+2,869,996
| +124% | +$382M |
|
219
News Corp Class A
NWSA
$15.5B
| $707M | 0.1% |
52,435,946
+4,850,224
| +10% | +$59.3M |
|
220
Franklin Resources
BEN
$16.9B
| $703M | 0.1% |
20,190,619
-1,750,468
| -8% | -$59.5M |
|
|
DAY
221
DELISTED
Dayforce
DAY
| $696M | 0.1% |
13,864,672
+3,312,089
| +31% | +$168M |
|
222
Casey's General Stores
CASY
$30.7B
| $687M | 0.1% |
4,405,842
-937,083
| -18% | -$128M |
|
223
Johnson Controls International
JCI
$93.7B
| $685M | 0.1% |
16,578,497
-5,618,825
| -25% | -$216M |
|
224
Cognizant
CTSH
$26.4B
| $675M | 0.09% |
10,652,397
+8,307,253
| +354% | +$545M |
|
225
State Street
STT
$51.4B
| $671M | 0.09% |
11,962,313
+2,323,171
| +24% | +$144M |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.